![Tumor Board webinar on The Role of Molecular Profiling in Uterine Cancer – National Comprehensive Cancer Network](https://oncodaily.com/pub/uploads/2024/08/1724766290226_upscayl_2x_realesrgan-x4plus-1280x720.png)
Tumor Board webinar on The Role of Molecular Profiling in Uterine Cancer – National Comprehensive Cancer Network
National Comprehensive Cancer Network shared a post on LinkedIn:
“Join us next week on September 4 for the Tumor Board webinar focusing on The Role of Molecular Profiling in the Management of Uterine Cancer.
Attendees will learn to integrate recent advances in molecular analysis and discuss how they affect systemic therapy selection for uterine cancer.
Register now”
Source: National Comprehensive Cancer Network/LinkedIn
Natalia Buza, MD is the Professor of Pathology at Yale School of Medicine. She is the Director of Pathology Center of Excellence for Women’s Health, Anatomic Pathology and Director of Gynecologic Pathology Fellowship Program, Anatomic Pathology.
She completed her residency training in Anatomic Pathology, followed by a Fellowship in Gynecologic and Breast pathology at Yale University. Dr. Buza has authored/co-authored over 140 publications in the field of gynecologic pathology, including several review articles, book chapters, and a textbook dedicated to Intraoperative Frozen Section in Gynecologic Pathology.
Shari Damast is the Professor of Therapeutic Radiology at Yale School of Medicine. She is also the Chief of the Gynecologic Radiotherapy Program in the department Therapeutic Radiology. City. Dr. Damast is a member of the American Society of Radiation Oncology (ASTRO), the American Brachytherapy Society (ABS), and the Scientific Network on Female Sexual Health and Cancer.
Elena Ratner, MD, MBA is the Professor of Obstetrics, Gynecology and Reproductive Sciences at Yale School of Medicine. She is also the Co-Chief of the Section of Gynecologic Oncology. Dr. Ratner is a Board Certified Gynecologic Oncologist with special interests in chemotherapy-targeted drug development. She is the current co-director of Discovery To Cure, director of Discovery to Cure Early Ovarian Cancer Detection program, and a founder and director of the Sexuality, Intimacy and Menopause cancer survivorship program.